v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at beginning of period at Dec. 31, 2024 $ 310 $ 157,073 $ (137,619) $ (2,483) $ 17,281
Balance at beginning of period (in shares) at Dec. 31, 2024 30,983,437        
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)     992   992
Unrealized loss on foreign exchange rate translation       (30) (30)
Stock-based compensation expense   44     44
Issuance of common stock as compensation (in shares) 1,050        
Shares exchanged for taxes on stock-based compensation (in shares) (325)        
Balance at end of period at Mar. 31, 2025 $ 310 157,117 (136,627) (2,513) 18,287
Balance at end of period (in shares) at Mar. 31, 2025 30,984,162        
Balance at beginning of period at Dec. 31, 2025 $ 311 157,154 (139,560) (2,097) $ 15,808
Balance at beginning of period (in shares) at Dec. 31, 2025 31,052,840       31,052,840
Increase (Decrease) in Stockholders' Equity          
Net Income (Loss)     7,661   $ 7,661
Unrealized loss on foreign exchange rate translation       (186) (186)
Stock-based compensation expense   47     47
Balance at end of period at Mar. 31, 2026 $ 311 $ 157,201 $ (131,899) $ (2,283) $ 23,330
Balance at end of period (in shares) at Mar. 31, 2026 31,052,840       31,052,840